Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer Prevention02:59

Cancer Prevention

6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Enhancing Geriatric Knowledge and Board Certification Outcomes Through AGS Pre-Conference Board Review Course.

Journal of the American Geriatrics Society·2025
Same author

Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study.

Cancers·2025
Same author

Clinical safety of a 1-h infusion of cisplatin approach in a broad cancer population.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2025
Same author

Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.

International journal of cancer·2025
Same author

Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Genomic and transcriptomic landscape of HER2-low breast cancer.

Breast cancer research and treatment·2024

相关实验视频

Updated: Jun 7, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K

一个介绍老年瘤学的入门课程

David J Gregorio1, Kana Lucero2, Sukeshi Patel Arora3

  • 1Hematology/Medical Oncology Fellow, Department of Internal Medicine, University of Texas Health Science Center at San Antonio Joe R. & Teresa Lozano Long School of Medicine, and Department of Veterans Affairs (VA), South Texas Veterans Health Care System, Audie L. Murphy Veterans Memorial Medical Center.

MedEdPORTAL : the journal of teaching and learning resources
|November 15, 2024
PubMed
概括

一个新的老年瘤学课程提高了学员的知识. 本课程解决了对老年人癌症专业护理的日益增长的需求,增强了瘤学家培训.

关键词:
基于案例的学习.老年医学 老年医学老年瘤学 老年瘤学老年病的医生 老年病的医生血液学 血液学 血液学在瘤学瘤学.

更多相关视频

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice
09:19

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice

Published on: February 2, 2019

9.8K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K

相关实验视频

Last Updated: Jun 7, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K
Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice
09:19

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice

Published on: February 2, 2019

9.8K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K

科学领域:

  • 老年瘤学 老年瘤学
  • 医学教育 医学教育
  • 瘤学培训 瘤学培训

背景情况:

  • 老年人瘤学教育对于老龄化人口至关重要.
  • 在实施老年瘤学课程方面存在重大差距.
  • 只有有限的资源可用于瘤学培训计划.

研究的目的:

  • 开发和实施一个正式的入门老年瘤学课程.
  • 在老年瘤学原则上教育瘤学和老年病学学员.

主要方法:

  • 为奖学员提供了为期5个会议的2个月的教学/研讨会课程.
  • 整合了交互式学习和基于案例的研讨会.
  • 通过前后知识评估和满意度调查进行评估.

主要成果:

  • 15名研究员 (11名瘤学,4名老年病学) 参与了研究.
  • 课程后的知识分数显著改善 (平均值7.1至9.8,p=.02).

结论:

  • 成功实施了一个入门老年瘤学课程.
  • 未来的计划包括实习生演示,内容改进和跨学科的适应.